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9
A number of molecular mechanisms have been used for sensing intracellular metabolites, including 10 e.g. RNA aptamers (8, 9) and metabolite-responsive transcription factors (TFs) (10, 11). The latter 11 have become particularly popular because many organisms have evolved TFs that respond to native 12 metabolites. In E. coli, for instance, about a third of TFs are known to respond to metabolites (12).
13
Metabolite-responsive TFs can be re-purposed as biosensors in a different host (13) or re-engineered 14 to respond to new ligands (14). The list of compounds for which biosensors have been developed is 15 growing quickly (11) and includes precursors to biosynthetic pathways as well as products from 16 secondary metabolism (15-19).
17
As illustrated in Figure 1A , for the purposes of biosensor design, metabolite-responsive TFs can be 18 conceptualized as the composition of two modules: a sensing module for the interaction between the 19 metabolite and the TF, and a regulation module where the TF controls the expression of a target gene.
20
Biosensors generally have one of four different architectures, depending on the type of interactions of 21 the sensing and regulation module. Examples of these biosensor architectures can be found across 22 diverse applications in metabolic engineering, see e.g. the reviews in (10, 11) or Table SF2 in the   23 Supplementary File S1.
24
Most applications require biosensors to be tunable, so that designers can adjust biosensor output to 
43
Here we sought to characterize the interdependency between tunable parameters and the dose- 
Results and Discussion

50
Design constraints in dose-response curves of metabolite biosensors
51
To study the relation between promoter tuning and biosensor function, we focused on metabolite-52 responsive TFs, the most widespread mechanism employed for sensing small molecules (10, 11, 25).
53
In these biosensors, a convenient tunable parameter is the affinity of the TF to the promoter operator 54 site, as it can be modified with rapid and cost-effective techniques such as random mutagenesis of 55 promoter sequence or changes in operator copy number or location (25, 26).
56
As a model system for our investigation, we focused on the lactose inducible system in Escherichia 57 coli. We built eight lacUV5-based promoters with different mutations at the LacI-binding operator site
58
(sequences in Figure 1C 
65
To quantify the differences among the biosensors, we computed their dose-response parameters as 66 defined in Figure 1B . We found a strong interdependency between the biosensor parameters for 67 varying operator sites. In particular, when dynamic range ( ) and threshold ( ) are plotted against 68 each other ( Figure 1D ), we found a fundamental constraint for biosensor design. The constraint 69 indicates that upon changes in operator affinity, biosensors with a broader dynamic range also display Figure 1A , we used 75 phenomenological models that describe the steady state of the sensing and regulation modules as
76
Hill functions of their inputs. In the case of the lac system, which corresponds to the repressed-77 repressor architecture in Figure 1A , the model reads 
96
From biophysical considerations, it is typically assumed that mutations to the promoter operator site 97 affect the TF-operator affinity (21, 26). In our phenomenological approach, we further assume that 98 changes to TF-operator affinity can be captured by perturbations to the K 2 parameter only. This 99 simplification allows us to model each strain in our library with a different value of K 2 . We numerically 100 computed the ( , ) parameters from the dose-response curves P = f 2 (f 1 (M)) for varying values of K 2 , 101 and fitted the model parameters to the (b, , ) triplets from our fluorescence data (see Methods).
102
Despite its simplified nature, the results in Figure 1D suggests that our phenomenological model 
where A is a function a 1 , b 1 , K 2 , and n 2 , shown in Supplementary File S1. For brevity, we report the 111 computation of the biosensor sensitivity in Supplementary File S1.
112
From Eqs. (2) and (3), we compute the biosensor dynamic range as 113 142
where 1 = a 1 /b 1 is the dynamic range of TF activity. The limit thresholds for the other architectures 143 can be found in Supplementary File S1. From the formula in Eq. (5) we also computed the maximal 144 dynamic range that is achievable with changes to the TF-operator affinity:
145
As shown in Supplementary File S1, the formula for max applies to all four biosensor architectures in 146 Figure 1A . Since Eq. (8) 
151
Orthogonal control of dynamic range and threshold
152
The results in Eqs. (4) and (5) Figure 2C . As shown in Supplementary File S1, we found that this strategy for orthogonal 158 control is valid in all other biosensor architectures in Figure 1A , thus suggesting a general principle for 159 biosensor design.
160
To test the predicted orthogonal control in our lac system, we used two complementary strategies.
161
First, we induced our strains in Figure 1C 
164
In addition to mutating the operator sites, the promoter strength was modified by replacing the -35 and
165
-10 regions of the lacUV5 promoter with those of the sequences from promoter P A1 of phage T7. The 166 P A1 promoter has a higher binding affinity to RNA polymerase (32), and hence an increased promoter 167 strength, which in our model corresponds to an increased value for a2 and 2.
168
We measured the dose-response curves of both sets of strains with RFP fluorescence, shown in 169 Figure 3A -B, and quantified the dose-response parameters in Figure 3C . promoter sequence perturbed at the -35 and -10 regions (yellow curve, Figure 3C ), we used the 180 parameters from the IPTG strains ( Figure 1C ) and re-fitted a 2 , b 2 and n 2 . We expected the P A1 181 promoter sequence to affect parameter a 2 only, but we needed to re-fit b 2 and n 2 as well. 
247
We also expect the use of other tunable parameters, such as the TF expression level, to produce 248 more drastic changes in dose-response curves than those we observed here, for example by affecting 249 the basal and maximal output simultaneously.
250
In this work we have deliberately used phenomenological models because they provide a versatile 
where !,! , !,! and !,! are computed from equations (2) by the maximum measured value, denoted ! , ! or ! . In Figure 1D we fitted all model parameters.
291
The green line is a model fit with parameters reported in Table SF1 in Supplementary File S1. In 292 Figure 3C (blue) we used the fitted parameters from Figure 1D (green) and re-fitted K 1 and b 1 . In 293 Figure 3C (yellow), we used the parameters from Figure 1D 
